Company & Sponsor Intelligence

McMaster University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials9
Recruiting4
Completed4
Countries1

Therapeutic footprint

adhdalzheimersdepressionocdout_of_scopepain_neuropathysubstance_use

Indexed studies

NCT05114187An Internet-Based Education Program for Care Partners of People Living With Dementia
alzheimers · Canada
NA
NCT06548399Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease
out_of_scope · Canada
RECRUITING
NCT04954586Feasibility of Pain Informed Movement for Knee OA
pain_neuropathy · Canada
NA
NCT00994786A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
ocd · Canada
PHASE4
NCT07671248Tirzepatide in the Treatment of Cannabis Use Disorder
substance_use · Canada
PHASE3
NCT00715858A Pilot Study of Inflammatory Markers in Alzheimer's Disease
alzheimers · Canada
PHASE3
NCT06597448Public Health Nurse-Peer Co-Led Group Cognitive Behavioral Therapy for Postpartum Depression
depression · Canada
NA
NCT07050225Evaluating a Digital Cognitive Training Intervention in Adults With ADHD
adhd ·
NA
NCT03785223A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
adhd · Canada
PHASE4

Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →